scholarly journals Cardiac expression patterns of endothelin‐converting enzyme (ECE) suggest a role of endothelin signaling in conduction system development

2007 ◽  
Vol 21 (5) ◽  
Author(s):  
David Sedmera ◽  
Brett S. Harris ◽  
Elizabeth Grant ◽  
Ning Zhang ◽  
Jane Jourdan ◽  
...  
2008 ◽  
Vol 237 (6) ◽  
pp. 1746-1753 ◽  
Author(s):  
David Sedmera ◽  
Brett S. Harris ◽  
Elizabeth Grant ◽  
Ning Zhang ◽  
Jane Jourdan ◽  
...  

2002 ◽  
Vol 103 (s2002) ◽  
pp. 353S-356S ◽  
Author(s):  
Benjamin A. DE CAMPO ◽  
Roy G. GOLDIE ◽  
Arco Y. JENG ◽  
Peter J. HENRY

The present study examined the roles of endothelin-converting enzyme (ECE), neutral endopeptidase (NEP) and mast cell chymase as processors of the endothelin (ET) analogues ET-1(1–21), ET-1(1–31) and big ET-1 in the trachea of allergic mice. Male CBA/CaH mice were sensitized with ovalbumin (10µg) delivered intraperitoneal on days 1 and 14, and exposed to aerosolized ovalbumin on days 14, 25, 26 and 27 (OVA mice). Mice were killed and the trachea excised for histological analysis and contraction studies on day 28. Tracheae from OVA mice had 40% more mast cells than vehicle-sensitized mice (sham mice). Ovalbumin (10µg/ml) induced transient contractions (15±3% of the Cmax) in tracheae from OVA mice. The ECE inhibitor CGS35066 (10µM) inhibited contractions induced by big ET-1 (4.8-fold rightward shift of dose-response curve; P<0.05), but not those induced by either ET-1(1–21) or ET-1(1–31). The chymase inhibitors chymostatin (10µM) and Bowman-Birk inhibitor (10µM) had no effect on contractions induced by any of the ET analogues used. The NEP inhibitor CGS24592 (10µM) inhibited contractions induced by ET-1(1–31) (6.2-fold rightward shift; P<0.05) but not ET-1(1–21) or big ET-1. These data suggest that big ET-1 is processed predominantly by a CGS35066-sensitive ECE within allergic airways rather than by mast cell-derived proteases such as chymase. If endogenous ET-1(1–31) is formed within allergic airways, it is likely to undergo further conversion by NEP to more active products.


Circulation ◽  
1999 ◽  
Vol 99 (2) ◽  
pp. 292-298 ◽  
Author(s):  
Satoshi Kaburagi ◽  
Koji Hasegawa ◽  
Tatsuya Morimoto ◽  
Makoto Araki ◽  
Tatsuya Sawamura ◽  
...  

2008 ◽  
Vol 8 ◽  
pp. 239-269 ◽  
Author(s):  
M. R. M. Jongbloed ◽  
E. A. F. Mahtab ◽  
N. A. Blom ◽  
M. J. Schalij ◽  
A. C. Gittenberger-de Groot

The cardiac conduction system (CCS) encompasses a complex system responsible for the coordinated contraction of the heart. In the developing heart, as well as in the adult heart, tissues of the (putative) CCS are characterized by different properties than the surrounding working myocardium, which can be observed on a histological level, as well as by the expression patterns of several immunohistological and molecular markers. In recent years, many markers have been studied that have helped to elucidate the processes involved in CCS development. It has become clear that multiple genes, cells and their interactions are involved in this complex process. In this article, an overview of the current knowledge of CCS development is supplied. Furthermore, several controversies regarding conduction system development are discussed, as well as the possible significance of embryologic development of the CCS for the development of arrhythmias later in life.


2008 ◽  
Vol 50 (3) ◽  
pp. 364-375 ◽  
Author(s):  
Patricia Martínez-Miguel ◽  
Viviana Raoch ◽  
Carlos Zaragoza ◽  
Jose Manuel Valdivielso ◽  
Manuel Rodríguez-Puyol ◽  
...  

Life Sciences ◽  
2013 ◽  
Vol 93 (25-26) ◽  
pp. e33
Author(s):  
Sunu B. Raharjo ◽  
Noriaki Yuniadi ◽  
Yoga Emoto ◽  
Kazuhiko Nakayama ◽  
Ganesja M./INS; Harimurti

2007 ◽  
Vol 106 (3) ◽  
pp. 361-369 ◽  
Author(s):  
Martin Smollich ◽  
Martin Götte ◽  
George W. Yip ◽  
Eng-Siang Yong ◽  
Christian Kersting ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document